Soluble nonclassical HLA generated by the metalloproteinase pathway

Human Immunology

Volumn 64, Issue 8, 2003, Pages 802-810

  Dong, Yuzhi ^a   Lieskovska, Jaroslava ^a   Kedrin, Dmitriy ^a   Porcelli, Steven ^b   Mandelboim, Ofer ^c   Bushkin, Yuri ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

CD1d; Metalloproteinase; Soluble nonclassical HLA; 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; CD1 ANTIGEN; CD1D ANTIGEN; HLA A ANTIGEN; HLA A2 ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; HLA-E ANTIGEN; HLA-G ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; MEMBRANE ENZYME; METALLOPROTEINASE; SOLUBLE NONCLASSICAL HLA ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL MEMBRANE; CELL SURFACE; CHEMISTRY; CONTROLLED STUDY; ENZYMOLOGY; GENETIC TRANSFECTION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOLOGY; METABOLISM; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STABILITY; SOLUBILITY; TUMOR CELL LINE;

EID: 0042209905     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(03)00093-4     Document Type: Article

References (48)

1. Pamer E, Cresswell P: Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol 16:323, 1998.
2. Carosella ED, Dausset J, Kirszenbaum M: HLA-G revisited. Immunol Today 17:407, 1996.
3. Moody DB, Porcelli SA: Intracellular pathways of CD1 antigen presentation. Nature Rev Immunol 3:11, 2003.
4. Carosella ED, Paul P, Moreau P, Rouas-Freiss N: HLA-G and HLA-E: fundamental and pathophysiological aspects. Immunol Today 21:532, 2000.
5. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR: Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 186:289, 1997.
6. Onno M, Pangault C, Le Friec G, Guilloux V, André P, Fauchet R: Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 164:6426, 2000.
7. Canchis PW, Bhan AK, Landau SB, Yang L, Balk SP, Blumberg RS: Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d. Immunology 80:561, 1993.
8. Braud VM, Allan DSJ, McMichael AJ: Functions of non-classical MHC and non-MHC-encoded class I molecules. Curr Opin Immunol 11:100, 1999.
9. Braud VM, Allan DSJ, Wilson D, McMichael AJ: TAP and tapasin-dependent HLA-E expression correlates with the binding of an MHC class I leader peptide. Curr Biol 8:1, 1997.
10. Romagnani C, Pietra G, Falco M, Millo E, Mazzarino P, Biassoni R, Moretta A, Moretta L, Mingari MC: Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc Natl Acad Sci USA 99: 11328, 2002.
11. Garcia P, Llano M, de Heredia AB, Willberg CB, Caparrus E, Aparicio P, Braud VM, Lupez-Botet M: Human T cell receptor-mediated recognition of HLA-E. Eur J Immunol 32:936, 2002.
12. Braud VM, Allan DSJ, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795, 1998.
13. Lee N, Malacko AR, Ishitani A, Chen M, Bajorath J, Marquardt H, Geraghty DE: The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:591, 1995.
14. Schmidt CM, Garrett E, Orr HT: Cytotoxic T lymphocyte recognition of HLA-G in mice. Hum Immunol 55:127, 1997.
15. Horuzsko A, Antoniou J, Tomlinson P, Portik-Dobos V, Mellor AL: HLA-G functions as a restriction element and a transplantation antigen in mice. Int Immunol 9:645, 1997.
16. Mandelboim O, Pazmany L, Davis DM, Vales-Gomez M, Reyburn HT, Rybalov B, Strominger JL: Multiple receptors for HLA-G on human natural killer cells. Proc Natl Acad Sci USA 94:14666, 1997.
17. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED: HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 166:5018, 2001.
18. Van Rood JJ, Van Leeuwan A, Van Santen MCT: Anti-HLA-A2 inhibitor in normal human serum. Nature 226: 366, 1970.
19. Charlton RK, Zmijewski CM: Soluble HL-A7 antigen: localization in the beta-lipoprotein fraction of human serum. Science 170:636, 1970.
20. Krangel MS: Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 163:1173, 1986.
21. Demaria S, Schwab R, Gottesman SRS, Bushkin Y: Soluble β2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J Biol Chem 269:6689, 1994.
22. Demaria S, Schwab R, Bushkin Y: The origin and fate of β2m-free MHC class I molecules induced on activated T cells. Cell Immunol 142:103, 1992.
23. Tse DB, Cantor CR, McDowell J, Pernis B: Recycling class I MHC antigens: Dynamics of internalization, acidification, and ligand-degradation in murine T lymphoblasts. J Mol Cell Immunol 2:315, 1986.
24. Dasgupta JD, Watkins S, Slayter H, Yunis EJ: Receptor-like nature of class I HLA: endocytosis via coated pits. J Immunol 141:2577, 1988.
25. Pickl WF, Holter W, Stockl J, Majdic O, Knapp W: Expression of beta 2-microglobulin-free HLA class I alpha-chains on activated T cells requires internalization of HLA class I heterodimers. Immunology 88:104, 1996.
26. Demaria S, DeVito-Haynes LD, Salter RD, Burlingham WJ, Bushkin Y: Peptide-conformed β2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinase. Hum Immunol 60:1216, 1999.
27. Demaria S, Bushkin Y: Soluble HLA proteins with bound peptides are released from the cell surface by the membrane metalloproteinase. Hum Immunol 61:1332, 2000.
28. Fujii T, Ishitani A, Geraghty DE: A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 153:5516, 1994.
29. Paul P, Cabestre FA, Ibrahim EC, Lefebvre S, Khalil-Daher I, Vazeux G, Quiles RM, Bermond F, Dausset J, Carosella ED: Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 61:1138, 2000.
30. Woolfson A, Milstein C: Alternative splicing generates secretory isoforms of human CD1. Proc Natl Acad Sci USA 91:6683, 1994.
31. Kojo S, Adachi Y, Tsutsumi A, Sumida T: Alternative splicing forms of the human CD1D gene in mononuclear cells. Biochem Biophys Res Commun 276:107, 2000.
32. Stam NJ, Vroom TM, Peters PJ, Pastoors EB, Ploegh HL: HLA-A and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol 2:113, 1990.
33. Sernee MF, Ploegh HL, Schust DJ: Why certain antibodies cross-react with HLA-A and HLA-G: Epitope mapping of two common MHC class I reagents. Mol Immunol 35:177, 1998.
34. Bushkin Y, Posnett DN, Pernis B, Wang CY: A new HLA-linked T cell membrane molecule, related to the β chain of the clonotypic receptor, is associated with T3. J Exp Med 164:458, 1986.
35. Ulbrecht M, Kellermann J, Johnson JP, Weiss EH: Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: evidence for inefficient peptide binding. J Exp Med 176:1083, 1992.
36. Spada FM, Sugita M, Watts GFM, Koezuka Y, Porcelli SA: Low expression but potent antigen presenting function of CD1d on monocyte lineage cells. Eur J Immunol 30:3468, 2000.
37. Shimizu Y, Geraghty DE, Koller BH, Orr HT, DeMars R: Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci USA 85:227, 1988.
38. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, Baltimore D: The selective down-regulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10:661, 1999.
39. Polakova K, Karpatova M, Russ G: Dissociation of β2-microglobulin is responsible for selective reduction of HLA class I antigenicity following acid treatment of cells. Mol Immunol 30:1223, 1993.
40. Hochman JH, Jiang H, Matyus L, Edidin M, Pernis B: Endocytosis and dissociation of class I MHC molecules labeled with fluorescent β2-microglobulin. J Immunol 146:1862, 1991.
41. Davis DM, Reyburn HT, Pazmany L, Chiu I, Mandelboim O, Strominger JL: Impaired spontaneous endocytosis of HLA-G. Eur J Immunol 10:2714, 1997.
42. Jayawardena-Wolf J, Benlagha K, Chiu YH, Mehr R, Bendelac A: CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15:897, 2001.
43. Bauer A, Huttinger R, Staffler G, Hansmann C, Schmidt W, Majdic O, Knapp W, Stockinger H: Analysis of the requirement for β2-microglobulin for expression and formation of human CD1 antigens. Eur J Immunol 27:1366, 1997.
44. Ernst WA, Maher J, Cho S, Niazi KR, Chatterjee D, Moody DB, Besra GS, Watanabe Y, Jensen PE, Porcelli SA, Kronenberg M, Modlin RL: Molecular interaction of CD1b with lipoglycan antigens. Immunity 8:331, 1998.
45. Tysoe-Calnon VA, Grundy JE, Perkins SJ: Molecular comparisons of the beta 2-microglobulin-binding site in class I major-histocompatibility-complex alpha-chains and proteins of related sequences. Biochem J 277:359, 1991.
46. Gromme M, Uytdehaag FG, Janssen H, Calafat J, van Binnendijk RS, Kenter MJ, Tulp A, Verwoerd D, Neefjes J: Recycling MHC class I molecules and endosomal peptide loading. Proc Natl Acad Sci USA 96:10326, 1999.
47. Doedens JR, Black RA: Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275:14598, 2000.
48. Barnea E, Beer I, Patoka R, Ziv T, Kessler O, Tzehoval E, Zavazava N, Admon A: Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens. Eur J Immunol 32:213, 2002.